Peter Martin
Language: English, Spanish, French
Gender: Male
520 East 70th Street, Starr Pavilion, 3rd Floor
New York, NY 10065
P: (646) 962-2064 | F: (646) 962-1605
Call for appointment
(646) 962-2064

Personal Statement

Our goal is to provide the best care possible for every person with lymphoma.  We are working every day to develop better treatments and integrate them into clinical practice.

Our approach involves a comprehensive team of cancer-care specialists. I believe that every person is unique, and I strive to develop a treatment plan that is individualized to each patient's needs. I am fortunate to work in a center where we can offer a range of therapies, including targeted therapies, immunotherapy, chemotherapy, radiation therapy, and stem cell transplantation.

I believe that everyone should have the opportunity to participate in a clinical trial. As a result of clinical trials open at Weill Cornell Medical College, our patients have had access to new treatments years before they became widely available. We have been involved in the development of virtually every drug approved for treatment of lymphoma over the past 15 years. The drug ibrutinib was approved for treatment of patients with mantle cell lymphoma and chronic lymphocytic leukemia, and it is under investigation in other lymphomas (diffuse large B-cell lymphoma, follicular lymphoma, marginal zone lymphoma, and Waldenstrom's macroglobulinemia). The drug idelalisib is approved for treatment of patients with chronic lymphocytic leukemia and follicular lymphoma and continues to be evaluated in other areas. Lenalidomide is approved for treatment of previously treated mantle cell lymphoma and is now being evaluated as first-line therapy in follicular lymphoma and mantle cell lymphoma. I am excited that we can offer these and other promising treatments and I am looking forward to a future where we have a personalized treatment for everyone.

View Biography


Board Certifications
  • Hematology
  • Internal Medicine
  • Hematology
  • Non-Hodgkin's Lymphoma
  • DLBCL (Diffuse Large B Cell Lymphoma)
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
  • Waldenstrom's Macroglobulinemia
  • Chronic Lymphocytic Leukemia
  • Hodgkin Lymphoma
  • Lymphoma

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.

* indicates this physician is no longer accepting new patients with this insurance plan.

  • AETNA [Medicare]
  • Aetna - Weill Cornell [POS]
  • Affinity Essential
  • Affinity Health Plan
  • Blue Priority Network
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [Pathway X]
  • Empire Blue Cross/Blue Shield [Pathway X Enhanced]
  • Empire Empire Blue Cross/Blue Shield HealthPlus
  • Empire Empire Blue Cross/Blue Shield HealthPlus [CHP]
  • Fidelis Care
  • GHI [CBP]
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Insurance Plan of NY (HIP)
  • Health Republic
  • Medicaid
  • Medicare
  • Oscar
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Freedom]
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care
  • United Health Care [Medicare]
  • United Health Care [Community Plan]
  • VNSNY CHOICE Medicare [Medicare]
  • VNSNY CHOICE Medicare [HMO]


  • B.Sc., University of Alberta (Canada), 1995
  • M.D., University of Alberta Faculty of Medicine (Canada), 2001
  • M.S., Cornell University, 2008

Honors and Awards

Dr. Ronald Oakley Prize in Anatomy 1998

Diane Dompe Memorial Scholarship in Medicine, for merit in medical oncology 2001

Amgen Canada Fellows Alliance Award 2005

Swiss League against Cancer Travel Award 2008

American Society of Clinical Oncology Young Investigator Award 2009

American Society of Hematology Clinical Research Training Institute 2009

The Charles, Lillian and Betty Neuwirth Clinical Scholar in Oncology 2013

Alliance Scholar Award, Alliance for Clinical Trials in Oncology 2014



Charles, Lillian, and Betty Neuwirth Clinical Scholar in Oncology
Weill Cornell Medical College

Assistant Attending Physician
NewYork-Presbyterian Hospital

Assistant Professor of Medicine
Weill Cornell Medical College, Cornell University


Dr. Peter Martin is an Assistant Professor of Medicine in the Division of Hematology/Oncology at Weill Cornell Medical College. A graduate of University of Alberta Medical School, Dr. Martin completed his residency in internal medicine and fellowship in hematology at McGill University. Prior to joining the faculty at Weill Cornell Medical College, he completed a Master's Degree in Clinical Investigation and Translational Research at the Weill Cornell School of Graduate Sciences.

Dr. Martin specializes in caring for patients with lymphoma. He is the Director of the Weill Cornell Clinical Research Program in Lymphoma. His research focuses on the clinical investigation of new and promising therapies, and he passionately believes that clinical trials are the gateway to a better future. In addition to being an investigator on clinical trials, Dr. Martin is the director of the Waterfall Waldenstrom's Macroglobulinemia Consortium and the Weill Cornell Lymphoma Database. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the Alliance for Clinical Trials in Oncology (ACTION, formerly Cancer and Leukemia Group B (CALGB)). He is board certified in Hematology and Internal Medicine by the American Board of Internal Medicine and the Royal College of Physicians and Surgeons of Canada. He has received awards and funding from the National Cancer Institute, the National Cancer Institute of Canada, the Leukemia and Lymphoma Society, the Lymphoma Research Foundation, the American Society of Hematology, and the American Society for Clinical Oncology for his research.



For More Videos, please see below:

Lymphoma Cancer Treatment NY - Weill Cornell